No abstract available
Keywords:
Thrombosis; Vaccination.
MeSH terms
-
Ad26COVS1
-
Adult
-
Aged, 80 and over
-
Algorithms
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Antiphospholipid Syndrome / complications
-
Antiphospholipid Syndrome / diagnosis
-
Australia / epidemiology
-
COVID-19 / diagnosis
-
COVID-19 / epidemiology
-
COVID-19 / prevention & control*
-
COVID-19 / virology
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / adverse effects*
-
ChAdOx1 nCoV-19
-
Combined Modality Therapy / methods
-
Enzyme-Linked Immunosorbent Assay / methods
-
Female
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage
-
Immunoglobulins, Intravenous / therapeutic use
-
Male
-
Mass Screening / methods
-
Middle Aged
-
New Zealand / epidemiology
-
Platelet Factor 4 / drug effects
-
Platelet Factor 4 / immunology
-
Purpura, Thrombocytopenic, Idiopathic / chemically induced*
-
Purpura, Thrombocytopenic, Idiopathic / diagnosis
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy
-
SARS-CoV-2 / genetics
-
SARS-CoV-2 / immunology
-
Thrombosis / chemically induced*
-
Thrombosis / diagnosis
-
Thrombosis / drug therapy
Substances
-
Ad26COVS1
-
Anticoagulants
-
COVID-19 Vaccines
-
Immunoglobulins, Intravenous
-
Platelet Factor 4
-
ChAdOx1 nCoV-19